Patents by Inventor Patrick AMSTUTZ

Patrick AMSTUTZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL SLOW-RELEASE PRODRUGS
    Publication number: 20240108746
    Abstract: The present invention relates to compositions comprising a binding moiety and a drug molecule, wherein said binding moiety reversibly binds to said drug molecule to form a prodrug complex that slowly releases the drug molecule upon administration in vivo. The present invention further relates to methods of forming such compositions and to methods of treatment using such compositions. Also described are binding moieties, nucleic acids encoding said binding moieties and methods of making these using host cells.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 4, 2024
    Inventors: Andreas BOSSHART, Julia AHLSKOG, Bernd SCHLERETH, Patrick AMSTUTZ, Simon FONTAINE
  • Ankyrin repeat binding proteins and their uses
    Patent number: 11466062
    Abstract: The present invention relates to recombinant binding proteins comprising one or more designed ankyrin repeat domains with binding specificity for coronavirus spike proteins, nucleic acids encoding such proteins, pharmaceutical compositions comprising such proteins or nucleic acids, and the use of such proteins, nucleic acids or pharmaceutical compositions in the treatment of coronavirus diseases, particularly diseases caused by SARS-CoV-2.
    Type: Grant
    Filed: May 6, 2021
    Date of Patent: October 11, 2022
    Assignee: MOLECULAR PARTNERS AG
    Inventors: Patrick Amstutz, Valerie Perrine Calabro, Marcel Walser
  • NOVEL ANKYRIN REPEAT BINDING PROTEINS AND THEIR USES
    Publication number: 20220235103
    Abstract: The present invention relates to recombinant binding proteins comprising one or more designed ankyrin repeat domains with binding specificity for coronavirus spike proteins, nucleic acids encoding such proteins, pharmaceutical compositions comprising such proteins or nucleic acids, and the use of such proteins, nucleic acids or pharmaceutical compositions in the treatment of coronavirus diseases, particularly diseases caused by SARS-CoV-2.
    Type: Application
    Filed: February 11, 2022
    Publication date: July 28, 2022
    Inventors: Patrick AMSTUTZ, Valerie Perrine CALABRO, Marcel WALSER
  • NOVEL ANKYRIN REPEAT BINDING PROTEINS AND THEIR USES
    Publication number: 20210347835
    Abstract: The present invention relates to recombinant binding proteins comprising one or more designed ankyrin repeat domains with binding specificity for coronavirus spike proteins, nucleic acids encoding such proteins, pharmaceutical compositions comprising such proteins or nucleic acids, and the use of such proteins, nucleic acids or pharmaceutical compositions in the treatment of coronavirus diseases, particularly diseases caused by SARS-CoV-2.
    Type: Application
    Filed: May 6, 2021
    Publication date: November 11, 2021
    Inventors: Patrick AMSTUTZ, Valerie Perrine CALABRO, Marcel WALSER